Eton Pharmaceuticals, Inc. (ETON) financial statements (2022 and earlier)

Company profile

Business Address 21925 W. FIELD PARKWAY
DEER PARK, IL 60010-7278
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14,40621,29512,06626,735
Cash and cash equivalents14,40621,29512,06626,735
Receivables5,47148473 
Inventory, net of allowances, customer advances and progress billings5501,242380 
Inventory5501,242380 
Prepaid expense   767
Other undisclosed current assets3,1772,1162,090 
Total current assets:23,60424,70115,00927,502
Noncurrent Assets
Operating lease, right-of-use asset104192160
Property, plant and equipment1158111,117773
Intangible assets, net (including goodwill)3,621575725 
Intangible assets, net (excluding goodwill)3,621575725 
Other noncurrent assets21406152
Total noncurrent assets:3,8611,6182,063825
TOTAL ASSETS:27,46526,31917,07228,327
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,1403,5141,9632,024
Accounts payable1,7742,3445751,421
Accrued liabilities1,3661,1701,388603
Debt1,418   
Other undisclosed current liabilities 280  
Total current liabilities:4,5583,7941,9632,024
Noncurrent Liabilities
Long-term debt and lease obligation159919 
Operating lease, liability159919
Other undisclosed noncurrent liabilities5,2476,6644,540 
Total noncurrent liabilities:5,2776,8624,559 
Total liabilities:9,83510,6566,5222,024
Stockholders' equity
Stockholders' equity attributable to parent17,63015,66310,55026,303
Common stock25241818
Additional paid in capital111,718107,79774,72072,153
Accumulated deficit(94,113)(92,158)(64,188)(45,868)
Total stockholders' equity:17,63015,66310,55026,303
TOTAL LIABILITIES AND EQUITY:27,46526,31917,07228,327

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues21,83239959 
Cost of revenue
(Cost of Goods and Services Sold)
(1,414)(286)(453) 
Other undisclosed gross profit(1,209)   
Gross profit:19,209(247)506 
Operating expenses(20,704)(26,864)(19,107)(10,321)
Operating loss:(1,495)(27,111)(18,601)(10,321)
Nonoperating expense(1,006)(859)  
Interest and debt expense365(884)  
Loss from continuing operations before equity method investments, income taxes:(2,136)(28,854)(18,601)(10,321)
Other undisclosed income (loss) from continuing operations before income taxes181884281(2,419)
Loss from continuing operations before income taxes:(1,955)(27,970)(18,320)(12,740)
Income tax expense   (2,579)
Loss before gain (loss) on sale of properties:(1,955)(27,970)(18,320)(15,319)
Other undisclosed net income   2,579
Net loss attributable to parent:(1,955)(27,970)(18,320)(12,740)
Other undisclosed net loss available to common stockholders, basic   (24,489)
Net loss available to common stockholders, diluted:(1,955)(27,970)(18,320)(37,229)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(1,955)(27,970)(18,320)(12,740)
Comprehensive loss, net of tax, attributable to parent:(1,955)(27,970)(18,320)(12,740)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: